Matches in SemOpenAlex for { <https://semopenalex.org/work/W2952300966> ?p ?o ?g. }
- W2952300966 endingPage "1886" @default.
- W2952300966 startingPage "1874" @default.
- W2952300966 abstract "Sodium/glucose cotransporter 1 (SGLT1), an essential active glucose transport protein that helps maintain high intracellular glucose levels, was previously shown to interact with epidermal growth factor receptor (EGFR); the SGLT1-EGFR interaction maintains intracellular glucose levels to promote survival of cancer cells. Here, we explore the role of SGLT1 in triple-negative breast cancer (TNBC), which is the most aggressive type of breast cancer. We performed TCGA analysis coupled to in vitro experiments in TNBC cell lines as well as in vivo xenografts established in the mammary fat pad of female nude mice. Tissue microarrays of TNBC patients with information of clinical-pathological parameters were also used to investigate the expression and function of SGLT1 in TNBC. We show that high levels of SGLT1 are associated with greater tumour size in TNBC. Knockdown of SGLT1 compromises cell growth in vitro and in vivo. We further demonstrate that SGLT1 depletion results in decreased levels of phospho-EGFR, and as a result, the activity of downstream signalling pathways (such as AKT and ERK) is inhibited. Hence, targeting SGLT1 itself or the EGFR-SGLT1 interaction may provide novel therapeutics against TNBC." @default.
- W2952300966 created "2019-06-27" @default.
- W2952300966 creator A5011616773 @default.
- W2952300966 creator A5013594735 @default.
- W2952300966 creator A5036550250 @default.
- W2952300966 creator A5050648940 @default.
- W2952300966 creator A5050666604 @default.
- W2952300966 creator A5058076484 @default.
- W2952300966 creator A5059105795 @default.
- W2952300966 creator A5061685303 @default.
- W2952300966 creator A5065312383 @default.
- W2952300966 creator A5065972394 @default.
- W2952300966 creator A5080052541 @default.
- W2952300966 creator A5084792906 @default.
- W2952300966 creator A5084807018 @default.
- W2952300966 creator A5090211368 @default.
- W2952300966 date "2019-07-10" @default.
- W2952300966 modified "2023-09-26" @default.
- W2952300966 title "SGLT1 is required for the survival of triple‐negative breast cancer cells via potentiation of EGFR activity" @default.
- W2952300966 cites W1490526451 @default.
- W2952300966 cites W1631575083 @default.
- W2952300966 cites W1774029313 @default.
- W2952300966 cites W1861588860 @default.
- W2952300966 cites W1981989535 @default.
- W2952300966 cites W1984621921 @default.
- W2952300966 cites W1992403457 @default.
- W2952300966 cites W1999159723 @default.
- W2952300966 cites W2005448278 @default.
- W2952300966 cites W2009785997 @default.
- W2952300966 cites W2016924160 @default.
- W2952300966 cites W2046775283 @default.
- W2952300966 cites W2056681493 @default.
- W2952300966 cites W2056787790 @default.
- W2952300966 cites W2065828547 @default.
- W2952300966 cites W2080320918 @default.
- W2952300966 cites W2080719056 @default.
- W2952300966 cites W2088089215 @default.
- W2952300966 cites W2092087030 @default.
- W2952300966 cites W2094882473 @default.
- W2952300966 cites W2095381863 @default.
- W2952300966 cites W2096283457 @default.
- W2952300966 cites W2097584581 @default.
- W2952300966 cites W2104024752 @default.
- W2952300966 cites W2106660927 @default.
- W2952300966 cites W2112720107 @default.
- W2952300966 cites W2117692326 @default.
- W2952300966 cites W2121467196 @default.
- W2952300966 cites W2121665844 @default.
- W2952300966 cites W2123275987 @default.
- W2952300966 cites W2133469996 @default.
- W2952300966 cites W2134539328 @default.
- W2952300966 cites W2143890940 @default.
- W2952300966 cites W2146404049 @default.
- W2952300966 cites W2149542756 @default.
- W2952300966 cites W2153769134 @default.
- W2952300966 cites W2156871941 @default.
- W2952300966 cites W2158217645 @default.
- W2952300966 cites W2161382947 @default.
- W2952300966 cites W2170292198 @default.
- W2952300966 cites W2191558617 @default.
- W2952300966 cites W2745924174 @default.
- W2952300966 cites W2746741726 @default.
- W2952300966 cites W2768583786 @default.
- W2952300966 cites W2883581800 @default.
- W2952300966 cites W2911718257 @default.
- W2952300966 cites W2933024894 @default.
- W2952300966 cites W51598435 @default.
- W2952300966 doi "https://doi.org/10.1002/1878-0261.12530" @default.
- W2952300966 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6717760" @default.
- W2952300966 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31199048" @default.
- W2952300966 hasPublicationYear "2019" @default.
- W2952300966 type Work @default.
- W2952300966 sameAs 2952300966 @default.
- W2952300966 citedByCount "20" @default.
- W2952300966 countsByYear W29523009662020 @default.
- W2952300966 countsByYear W29523009662021 @default.
- W2952300966 countsByYear W29523009662022 @default.
- W2952300966 countsByYear W29523009662023 @default.
- W2952300966 crossrefType "journal-article" @default.
- W2952300966 hasAuthorship W2952300966A5011616773 @default.
- W2952300966 hasAuthorship W2952300966A5013594735 @default.
- W2952300966 hasAuthorship W2952300966A5036550250 @default.
- W2952300966 hasAuthorship W2952300966A5050648940 @default.
- W2952300966 hasAuthorship W2952300966A5050666604 @default.
- W2952300966 hasAuthorship W2952300966A5058076484 @default.
- W2952300966 hasAuthorship W2952300966A5059105795 @default.
- W2952300966 hasAuthorship W2952300966A5061685303 @default.
- W2952300966 hasAuthorship W2952300966A5065312383 @default.
- W2952300966 hasAuthorship W2952300966A5065972394 @default.
- W2952300966 hasAuthorship W2952300966A5080052541 @default.
- W2952300966 hasAuthorship W2952300966A5084792906 @default.
- W2952300966 hasAuthorship W2952300966A5084807018 @default.
- W2952300966 hasAuthorship W2952300966A5090211368 @default.
- W2952300966 hasBestOaLocation W29523009661 @default.
- W2952300966 hasConcept C121608353 @default.
- W2952300966 hasConcept C126322002 @default.
- W2952300966 hasConcept C150903083 @default.
- W2952300966 hasConcept C173396325 @default.